A 75-year-old patient with metastatic renal cell carcinoma was treated with recombinant interferon alpha-C and thereafter developed a neurologic syndrome of dementia, ataxia, confusional state, loss of concentration ability and cortical blindness. CT scan findings were compatible with leukoencephalopathy, which is reported as being a toxic effect of interferon.
Get full access to this article
View all access options for this article.
References
1.
AdamsF., QuesadaJ.R., GuttermanJ.U.: Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer, JAMA, 252: 938–941, 1984.
2.
CarrollB.A., LaneB., NormanD., EnzmannD.: Diagnosis of progressive multifocal leukoencephalopathy by computed tomography.Radiology, 122: 137–141, 1977.
3.
HarterD.H.: Diseases caused by slow viruses. In: Harrison's Principles of Internal Medicine.IsselbacherK.J., AdamsR.D., BraunwaldE., PetersdorfR.G., WilsonJ.D. (Eds.), pp. 844–846, 9th ed., McGraw Hill, New York, 1980.
4.
KirkwoodJ.M., ErnstoffM.S., DavisC.A., ReissM., FerraresiR., RudnikS.A.: Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers.Ann. Intern. Med., 103: 32–36, 1985.
5.
KrownS.E.: Interferons and interferon inducers in cancer treatment.Semin. Oncol., 13: 207–217, 1986.
6.
MerimskyO., Rieder-GroswasserI., InbarM., ChaitchikS.: Interferon-related mental deterioration and behavioral changes in patients with renal cell carcinoma.Eur. J. Cancer, 26: 596–600, 1990.
7.
SmedleyH., KatrakM., SikoraK., WheelerT.: Neurological effects of recombinant human interferon. Br. Med. J. (Clin.Res.), 286: 262–264, 1983.
